Children diagnosed with ALL in their first year of life (defined worldwide as infants) have a remarkably poorer prognosis compared with older children; this is largely explained by the biology of their ALL, as ~75–80% of them carry a KMT2A gene rearrangement. Here, KMT2A is linked to acute lymphoblastic leukemia.